Efficient induction of pancreatic alpha cells from human induced pluripotent stem cells by controlling the timing for BMP antagonism and activation of retinoic acid signaling.

Diabetes mellitus is caused by breakdown of blood glucose homeostasis, which is maintained by an exquisite balance between insulin and glucagon produced respectively by pancreatic beta cells and alpha cells. However, little is known about the mechanism of inducing glucagon secretion from human alpha...

Full description

Bibliographic Details
Main Authors: Shigeharu G Yabe, Satsuki Fukuda, Junko Nishida, Fujie Takeda, Kiyoko Nashiro, Hitoshi Okochi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0245204&type=printable
_version_ 1826574412779880448
author Shigeharu G Yabe
Satsuki Fukuda
Junko Nishida
Fujie Takeda
Kiyoko Nashiro
Hitoshi Okochi
author_facet Shigeharu G Yabe
Satsuki Fukuda
Junko Nishida
Fujie Takeda
Kiyoko Nashiro
Hitoshi Okochi
author_sort Shigeharu G Yabe
collection DOAJ
description Diabetes mellitus is caused by breakdown of blood glucose homeostasis, which is maintained by an exquisite balance between insulin and glucagon produced respectively by pancreatic beta cells and alpha cells. However, little is known about the mechanism of inducing glucagon secretion from human alpha cells. Many methods for generating pancreatic beta cells from human pluripotent stem cells (hPSCs) have been reported, but only two papers have reported generation of pancreatic alpha cells from hPSCs. Because NKX6.1 has been suggested as a very important gene for determining cell fate between pancreatic beta and alpha cells, we searched for the factors affecting expression of NKX6.1 in our beta cell differentiation protocols. We found that BMP antagonism and activation of retinoic acid signaling at stage 2 (from definitive endoderm to primitive gut tube) effectively suppressed NKX6.1 expression at later stages. Using two different hPSCs lines, treatment with BMP signaling inhibitor (LDN193189) and retinoic acid agonist (EC23) at Stage 2 reduced NKX6.1 expression and allowed differentiation of almost all cells into pancreatic alpha cells in vivo after transplantation under a kidney capsule. Our study demonstrated that the cell fate of pancreatic cells can be controlled by adjusting the expression level of NKX6.1 with proper timing of BMP antagonism and activation of retinoic acid signaling during the pancreatic differentiation process. Our method is useful for efficient induction of pancreatic alpha cells from hPSCs.
first_indexed 2024-12-21T01:46:43Z
format Article
id doaj.art-ae2a49174858477e8c88ab1a775e4ca2
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2025-03-14T12:58:24Z
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-ae2a49174858477e8c88ab1a775e4ca22025-03-02T05:32:15ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01161e024520410.1371/journal.pone.0245204Efficient induction of pancreatic alpha cells from human induced pluripotent stem cells by controlling the timing for BMP antagonism and activation of retinoic acid signaling.Shigeharu G YabeSatsuki FukudaJunko NishidaFujie TakedaKiyoko NashiroHitoshi OkochiDiabetes mellitus is caused by breakdown of blood glucose homeostasis, which is maintained by an exquisite balance between insulin and glucagon produced respectively by pancreatic beta cells and alpha cells. However, little is known about the mechanism of inducing glucagon secretion from human alpha cells. Many methods for generating pancreatic beta cells from human pluripotent stem cells (hPSCs) have been reported, but only two papers have reported generation of pancreatic alpha cells from hPSCs. Because NKX6.1 has been suggested as a very important gene for determining cell fate between pancreatic beta and alpha cells, we searched for the factors affecting expression of NKX6.1 in our beta cell differentiation protocols. We found that BMP antagonism and activation of retinoic acid signaling at stage 2 (from definitive endoderm to primitive gut tube) effectively suppressed NKX6.1 expression at later stages. Using two different hPSCs lines, treatment with BMP signaling inhibitor (LDN193189) and retinoic acid agonist (EC23) at Stage 2 reduced NKX6.1 expression and allowed differentiation of almost all cells into pancreatic alpha cells in vivo after transplantation under a kidney capsule. Our study demonstrated that the cell fate of pancreatic cells can be controlled by adjusting the expression level of NKX6.1 with proper timing of BMP antagonism and activation of retinoic acid signaling during the pancreatic differentiation process. Our method is useful for efficient induction of pancreatic alpha cells from hPSCs.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0245204&type=printable
spellingShingle Shigeharu G Yabe
Satsuki Fukuda
Junko Nishida
Fujie Takeda
Kiyoko Nashiro
Hitoshi Okochi
Efficient induction of pancreatic alpha cells from human induced pluripotent stem cells by controlling the timing for BMP antagonism and activation of retinoic acid signaling.
PLoS ONE
title Efficient induction of pancreatic alpha cells from human induced pluripotent stem cells by controlling the timing for BMP antagonism and activation of retinoic acid signaling.
title_full Efficient induction of pancreatic alpha cells from human induced pluripotent stem cells by controlling the timing for BMP antagonism and activation of retinoic acid signaling.
title_fullStr Efficient induction of pancreatic alpha cells from human induced pluripotent stem cells by controlling the timing for BMP antagonism and activation of retinoic acid signaling.
title_full_unstemmed Efficient induction of pancreatic alpha cells from human induced pluripotent stem cells by controlling the timing for BMP antagonism and activation of retinoic acid signaling.
title_short Efficient induction of pancreatic alpha cells from human induced pluripotent stem cells by controlling the timing for BMP antagonism and activation of retinoic acid signaling.
title_sort efficient induction of pancreatic alpha cells from human induced pluripotent stem cells by controlling the timing for bmp antagonism and activation of retinoic acid signaling
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0245204&type=printable
work_keys_str_mv AT shigeharugyabe efficientinductionofpancreaticalphacellsfromhumaninducedpluripotentstemcellsbycontrollingthetimingforbmpantagonismandactivationofretinoicacidsignaling
AT satsukifukuda efficientinductionofpancreaticalphacellsfromhumaninducedpluripotentstemcellsbycontrollingthetimingforbmpantagonismandactivationofretinoicacidsignaling
AT junkonishida efficientinductionofpancreaticalphacellsfromhumaninducedpluripotentstemcellsbycontrollingthetimingforbmpantagonismandactivationofretinoicacidsignaling
AT fujietakeda efficientinductionofpancreaticalphacellsfromhumaninducedpluripotentstemcellsbycontrollingthetimingforbmpantagonismandactivationofretinoicacidsignaling
AT kiyokonashiro efficientinductionofpancreaticalphacellsfromhumaninducedpluripotentstemcellsbycontrollingthetimingforbmpantagonismandactivationofretinoicacidsignaling
AT hitoshiokochi efficientinductionofpancreaticalphacellsfromhumaninducedpluripotentstemcellsbycontrollingthetimingforbmpantagonismandactivationofretinoicacidsignaling